CAS 1417318-27-4

Utomilumab

CAS: 1417318-27-4

Utomilumab, a humanized IgG2 against T-cell receptor 4-1BB/CD137, shows antitumor effects in advanced cancers.

Formula: C₁₇H₂₄N₈O₃

Purezza: 95% - 95.1% (SDS-PAGE); 98.5% (SEC-HPLC)

Colore e forma: Liquid

Peso molecolare: 142.77 kDa

Ref: TM-T76705

Utomilumab

CAS: 1417318-27-4

Anti-Human CD137 Monoclonal Antibody

Ref: 3D-CLA1450